H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The company has a quick ratio of 0.71, a current ratio of 1.15 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The company’s 50 day moving average is $22.00 and its 200-day moving average is $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Recommended Stories
- Five stocks we like better than H. Lundbeck A/S
- The Most Important Warren Buffett Stock for Investors: His Own
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Does a Stock Split Mean?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- High Flyers: 3 Natural Gas Stocks for March 2022
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
